HAVIT Blog
Science-backed guides on habits, sleep, nutrition, and movement.
All articles
GLP-1 Plotter: Chart Your Medication Level & Weight Over Time
A GLP-1 plotter charts your medication level between weekly doses, your weight-trend curve, and your dose timeline — so you can see the whole picture, not one number.
GLP-1 Postpartum: Breastfeeding Safety & Weight (2026)
GLP-1s are not recommended while breastfeeding. The FDA Wegovy (semaglutide) label states breastfeeding is not recommended during treatment, and clinical guidance advises avoiding tirzepatide while nursing. GLP-1s must also be stopped in pregnancy. Any use for postpartum weight loss is an individual decision to make with your OB-GYN — usually only once you are no longer breastfeeding.
GLP-1 Progress Tracker: See Results Beyond the Scale
A GLP-1 progress tracker follows your weight trend, body composition, measurements, photos and non-scale victories — so you see real progress even when the scale stalls.
GLP-1 Shot Tracker: Log Every Weekly Injection & Site
A GLP-1 shot tracker logs each weekly injection — date, rotated site, and missed-dose window for Wegovy, Ozempic & tirzepatide. See exactly how to track a shot.
Injection Tracker App for GLP-1: Features to Look For
Choosing an injection tracker app for GLP-1? Here are the must-have features — site-rotation body map, weekly reminders, dose log, missed-dose logic — and why it beats paper.
Lose It! Alternative for GLP-1 Users: An Honest 2026 Comparison — Havit vs Lose It
Looking for a Lose It! alternative on Ozempic or Zepbound? What Lose It! does well as a calorie counter, where it falls short for GLP-1, and what to look for.
MacroFactor Alternative for GLP-1 Users: An Honest 2026 Comparison — Havit vs MacroFactor
Looking for a MacroFactor alternative on a GLP-1? What MacroFactor's macro coaching does brilliantly, why it doesn't track your dose, and what to look for.
Oral Wegovy Side Effects: Nausea & Warnings (2026)
Oral Wegovy's most common side effects are gastrointestinal — nausea, diarrhea, vomiting, constipation, and abdominal pain — usually mild-to-moderate and worst during dose increases. Because oral Wegovy is the same molecule as injectable Wegovy (semaglutide), it shares the *same* side-effect profile and the *same* serious warnings, including pancreatitis, gallbladder disease, and a boxed thyroid warning.
Orforglipron Side Effects: Nausea, Warnings (2026)
Orforglipron's most common side effects are gastrointestinal — nausea, diarrhea, constipation, and vomiting — which are dose-dependent, tend to be worst around each dose increase, and usually settle as the body adapts. Rare but serious risks include a boxed warning for thyroid C-cell tumors plus pancreatitis and gallbladder disease, which need urgent medical care.
Phaze Alternative for GLP-1 Users: An Honest 2026 Comparison — Havit vs Phaze
Looking for a Phaze alternative on Ozempic or Zepbound? What Phaze does well, where it fits best, and how HAVIT compares as a whole-lifestyle alternative.
Pillyze Alternative for GLP-1 Users: An Honest 2026 Comparison — Havit vs Pillyze
Looking for a Pillyze alternative on a GLP-1? Pillyze is a strong diet, supplement, and glucose app — but it doesn't track your shot. How HAVIT compares.
Retatrutide Side Effects: Trial Data & Warnings 2026
In clinical trials, retatrutide's most common side effects are gastrointestinal — nausea, diarrhea, constipation, and vomiting — mostly mild-to-moderate and worst during dose escalation. Its triple-agonist design also produces two distinctive signals: abnormal skin sensations (dysesthesia) and a modest heart-rate increase. Retatrutide is investigational and available only through clinical trials — it cannot be prescribed.
